Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesLevetiracetam in spinal cord injury pain: a randomized controlled trial
Spinal Cord, 06/11/09
Finnerup NB et al. – Levetiracetam does not relieve neuropathic pain or spasm severity after spinal cord injury.
Methods- Randomized, double-blind, placebo-controlled, crossover, multicenter trial of the anticonvulsant levetiracetam
- Baseline 1-wk period followed by two 5-wk treatment periods with levetiracetam increased from 500 mg bid to maximum of 1500 mg bid; 1-wk washout periods
- Primary aim: study of the efficacy in pts with spinal cord injury (SCI) at- and below-level pain
- Secondary aim: study of the effect on spasm severity
- Setting: Outpatients at 2 spinal cord units and a pain center
- Allowance of continued usual pain treatment at constant dose
- Primary outcome measure: change in median daily pain score (0–10 point rating scale) from 1-wk baseline period to last wk of each treatment period
- Secondary outcome measures: pain relief of at- and below-level pain, allodynia, spasms and spasticity
- Of 36 pts enrolled, 24 pts completed the trial
- No effect of levetiracetam on primary or secondary outcome measures
- Only 2 pts continued levetiracetam treatment after trial
- At 6-mo follow-up, 1 pt still in levetiracetam treatment
- Levetiracetam generally well tolerated with no serious adverse events
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial
The Lancet, 10/13/09
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09
Today in Pain Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial
The Lancet, 10/13/09
Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial
Diabetic Medicine, 10/01/09
Topiramate in migraine progression
The Journal of Headache and Pain, 10/20/09
Today in Spine...keeping you current
Receive free subspecialty "5-minute updates" via email
Cervical Radicular Pain
Pain Practice, 10/07/09
Paraplegia Following Image-Guided Transforaminal Lumbar Spine Epidural Steroid Injection: Two Case Reports
Pain Medicine, 10/29/09
Clinically isolated acute transverse myelitis: prognostic features and incidence
Multiple Sclerosis, 10/09/09
Today in Trauma...keeping you current
Receive free subspecialty "5-minute updates" via email
A population-based study of risk of epilepsy after hospitalization for traumatic brain injury
Epilepsia, 10/26/09
Clinical management and functional neuromonitoring in traumatic brain injury in children
Current Opinion in Pediatrics, 10/23/09
Emergency Department Assessment of Mild Traumatic Brain Injury and the Prediction of Postconcussive Symptoms: A 3-Month Prospective Study
Journal of Head Trauma Rehabilitation, 10/27/09
Sponsor
Article Search
Sponsor